From sequence to scale: Gene editing’s new era in biologics manufacturing

ConferencePositive

AI Analysis

Summary

Demeetra's CEO Jack Crawford and NorthX Biologics' CCO Magnus Gustavsson discuss advancements in cell line development and gene editing technologies for accelerating biologics manufacturing from development to GMP scale in a podcast episode.

Importance:2/10

Sentiment:

0.30

gene editingcell line developmentbiologics manufacturingCHO cellstransposasesGMPpodcast

Read the original article

Published by BioSpace on July 10, 2026 3:23 PM

Read Original